Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Pain, Paraesthesia, Polyarthritis, Raynaud's phenomenon
Clinical narrative: Inflammatory Polyarthropathy/ramdom and diffuse body pain; Paresthesia; Neuroma; Peripheral Neuropathy; Raynaud's Phenomenon; Fibromyalgia; Severe fatigue; Brain fog; Menstrual dysfunction; Autoimmune and Neurological injuries; Autoimmune and Neurological injuries; Problems with memory; Aconstellation of adverse symptoms, complications, injuries and other adverse events; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a 26-year-old female patient. The patient's concurrent conditions, medical history and concomitant medication were not provided.  Upon diagnosis of a suspect pap smear, patient health care provider, recommended quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) vaccination. On 15-MAY-2019, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (Lot #, expiration date, dose, route of administration and anatomical location of vaccine were not provided) for preventing cervical cancer. The patient second dose was administered in 23-OCT-2019.On an unspecified date, following vaccination, the patient started experiencing, sustained serious autoimmune and neurological injuries as a result of her vaccination it began with a random and diffuse body pain, which persisted over time. After seeing numerous specialists, the patient was diagnosed with various medical conditions, including but not limited to, inflammatory polyarthropathy, paresthesia, neuroma, peripheral neuropathy, Raynaud's phenomenon, fibromyalgia, severe fatigue, brain fog, and menstrual dysfunction. As a result of her symptoms, the patient had been unable to engage in normal activities. Following the vaccinations, the patient physical symptoms made attending college difficult. Also, she had problems with memory and brain fog, all of which was interfering with her daily life, making the simplest task, more difficult to perform.As a proximate result of vaccination, the patient  suffered and continues to suffer severe and permanent physical injuries, and associated symptomology and has suffered severe and permanent emotional injuries, including pain and suffering. Patient also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL).As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) l-induced injuries, the patient had suffered and continues to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity and she will continue to incur these losses and expenses in the future. The events outcome was not recovered. The reporter considered the events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL)   Upon internal review the event of Autoimmune disorder was considered as medically significant.